Answers are grounded in this paper and cite their sources.
Structured Summary Objectives To report outcomes and complications of endoscopic silicone laryngeal stenting in dogs with laryngeal paralysis, describe how the stent works, and assess whether presentation influences outcome. Methods Single-center, single-surgeon retrospective series of 31 dogs (August 2022 to August 2026). Before outcomes were known, dogs were assigned to Group A (stent as treatment, n = 24) or Group B (presented in crisis, with aspiration pneumonia, after failed airway surgery or with structural laryngeal disease, n = 7). Deaths and aspiration pneumonia were adjudicated blind to outcome. A printed model of a cadaver larynx with a stent in place was scanned by computed tomography. Results No death and no aspiration pneumonia was adjudicated stent-related; one dog regurgitating before placement developed aspiration pneumonia of indeterminate cause. Three dogs (9.7%) died within 30 days. Four (12.9%) developed delayed cricotracheal stricture, managed by bougienage and longer stents; 13 (41.9%) needed revision. Kaplan–Meier all-cause survival was 54.1% at 1 year (median 465 days, 95% CI 154 to 1390). Mortality was 10 of 24 dogs in Group A and 4 of 7 in Group B. Stridor and effort were relieved in 22 of 27 evaluable dogs. In the model, the stent pressed both arytenoids outward. Clinical Significance Seated from the vocal process to the first or second tracheal ring and sized to fill the larynx, the stent pushes both arytenoids open while leaving the epiglottis free to close. Because this disease also affects the esophagus, aftercare is esophageal care, and presentation should guide counseling.
No takes yet. Share an insight, caveat, or question.
Garner et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: